Skip to main content
Premium Trial:

Request an Annual Quote

Nasdaq Warns Helicos of Potential Delisting

Premium

This story was originally published Oct. 15.

Helicos has received a letter from Nasdaq stating that it has failed to regain compliance with the exchange's minimum bid price requirement and that its shares could be suspended on Oct. 21.

Helicos received the delisting determination letter on Oct. 12, according to documents filed on Friday with the US and Securities Exchange Commission.

Nasdaq notified the firm in April that its shares had closed below its minimum $1 per share bid price for 30 consecutive business days. Helicos would have been able to regain compliance by achieving a closing bid price of at least $1 for 10 consecutive business days before Oct. 11 (IS 4/20/2010).

The company's shares have hovered around $0.50 since September and closed at $0.43 on Friday.

Helicos said that it "expects to appeal" the determination, which will stay the delisting until the Nasdaq hearings panel issues a written decision.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.